Interv Akut Kardiol. 2003;2(4):167
Interv Akut Kardiol. 2003;2(4):172-177
Percutaneous transluminary pulmonary valvuloplasty (PTPV) is a treatment of choice of congenital pulmonic valvular stenosis. Method: Since its first performance in 1982, PTPV is used in treatment of pulmonic stenosis, mostly in children. In adults, PTPV is much less common. Results: Since January 1996, we performed PTPV in 5 adult patients with good immediate results and without any significant complications. The follow up of 4 of these patients shows persisting good effect of the procedure. Conclusion: PTPV represents a safe method with high procedural success and low risk of complications. Therefore it is accepted as a treatment of choice both...
Interv Akut Kardiol. 2003;2(4):178-183
Aim of the study: To compare the efficiency of unfractionated heparin (UFH) with low-molecular weight heparin (LMWH) – dalteparin – during percutaneous coronary interventions (PCI), to compare their effect on platelets and the „rebound“ phemonenon after their cessation. Methods: UFH in the dose of 100 units/kg of body weight or dalteparin in the dose of 80 units/kg were given intravenously to 340 patients in a randomized study. The clinical course was studied in all patients. The efficiency of anticoagulation, aggregation response of platelets, levels of betathromboglobulin (beta-TG), thromboxan B2 (TxB2), trombin-antithrombin...
Interv Akut Kardiol. 2003;2(4):184-189
The interval from onset of symptoms to the start of treatment in acute myocardial infarction (AMI) is substantially shortened by using prehospital thrombolysis. The cumulative analysis of studies comparing prehospital and hospital thrombolysis proves statistically significant reduction of short-time and long-time mortality in prehospital thrombolysis. That profit is similar to primary percutaneous transluminal coronary angioplasty (PTCA) in comparison with hospital thrombolysis. The basic problem is record of 12leads ECG and its interpretation since thrombolysis is indicated only in the presence of ST segment elevation or recent bundle branch block....
Interv Akut Kardiol. 2003;2(4):190-197
A review is given about the present state of nuclear cardiology, particularly about the progress in single photon emission computed tomography (SPECT). ECG-gated SPECT examination is a current standard which makes possible the evaluation of left ventricular (LV) myocardial perfusion and function. A spectrum of patients referred for this examination changes significantly. Myocardial perfusion SPECT plays the important role in diagnostics of coronary artery disease (CAD), however, there is nowadays growing significance of the evaluation of prognosis in patients known or suspected CAD, detection of ischemia CAD in some patients after...
Interv Akut Kardiol. 2003;2(4):205-207
Interv Akut Kardiol. 2003;2(4):198-201
The paper describes the case of a 42-year-old man with hemodynamically significant congenital pulmonary valve stenosis. The patient was symptomatic on pharmacological therapy, with exercise dyspnoe NYHA III, there was a peak gradient of 137 mmHg on pulmonary valve and a heavy hypertrophy of the right ventricle with the wall thickness of 20 mm on echocardiographic examination. The significant pulmonary stenosis with gradient of 165 mmHg was confirmed on catheterization, the percutaneous ballon pulmonary valvuloplasty was performed and the gradient dropped to 53 mmHg immediately. The patient was improved to functional class NYHA II after 3 months...
Interv Akut Kardiol. 2003;2(4):202-204
Use of positive inotropic phosphodiesterase inhibitor Milrinone in treatment of severe heart failure is known and aviable for several years. In spite of it an exploitation of Milrinone is minimal in the Czech Republic. One reason of this situation next to the higher price is probably a worry of adverse effects and only temporary positive effect of this medication. We have treated with Milrinone repeatedly and successfully patients with severe heart failure refractory to standard treatment. We were successful despite of high age of our patients, unsuitability of revascularisations or other causal treatment and many relative contraindications of Milrinone...
Interv Akut Kardiol. 2003;2(4):208
Interv Akut Kardiol. 2003;2(4):209-210
Interv Akut Kardiol. 2003;2(4):211-213
Interv Akut Kardiol. 2003;2(4):214-215
Interv Akut Kardiol. 2003;2(4):216-217
Interv Akut Kardiol. 2003;2(4):218-220